UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
SAE technical paper series, Volume 2005-01-0451.
eJournal
Journal of gastroenterology, ISSN 0944-1174, 3/2019, Volume 54, Issue 3, pp. 291 - 296
Pibrentasvir | NS5A RAVs | Medicine & Public Health | Glecaprevir | Colorectal Surgery | Hepatology | Gastroenterology | Abdominal Surgery | NS5A-P32 deletion | Surgical Oncology | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Quinoxalines - adverse effects | Recurrence | Antiviral Agents - therapeutic use | Humans | Japan | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Retreatment | Sulfonamides - therapeutic use | Antiviral Agents - adverse effects | Treatment Failure | Aged, 80 and over | Sulfonamides - adverse effects | Female | Aged | Benzimidazoles - therapeutic use | Quinoxalines - therapeutic use | Care and treatment | Analysis | Liver | Drug resistance | Hepatitis C virus | Hepatitis C | Health aspects | Genotype & phenotype | Hepatitis | Fibrosis | Interferon | Patients | Genotypes | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 03/2019, Volume 393, Issue 10176, pp. 1128 - 1137
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Japan - epidemiology | Mucocutaneous Lymph Node Syndrome - drug therapy | Health Status Indicators | Humans | Immunosuppressive Agents - therapeutic use | Child, Preschool | Immunoglobulins, Intravenous - administration & dosage | Male | Mucocutaneous Lymph Node Syndrome - immunology | Treatment Outcome | Incidence | Mucocutaneous Lymph Node Syndrome - genetics | Cyclosporine - therapeutic use | Coronary Vessel Anomalies - epidemiology | Immunoglobulins, Intravenous - therapeutic use | Drug Resistance - immunology | Cyclosporine - administration & dosage | Female | Mucocutaneous Lymph Node Syndrome - diagnosis | Drug Therapy, Combination | Child | Coronary Vessel Anomalies - prevention & control | Medicine, Experimental | Medical research | Product development | Kawasaki disease | Cyclosporine | Transcription factors | Intravenous administration | Calcium | Pathogenesis | Clinical trials | Nuclear engineering | Risk | NF-AT protein | Evidence-based medicine | Randomization | Illnesses | Lymphocytes | Immunoglobulins | Echocardiography | Research & development--R&D | Abnormalities | Coronary artery | Health risks | Patients | Fever | Disease prevention | Nuclear safety | Coronary vessels | Mucocutaneous lymph node syndrome | Health risk assessment | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
Scientific reports, ISSN 2045-2322, 09/2020, Volume 10, Issue 1, pp. 14880 - 14880
Journal Article
Scientific reports, ISSN 2045-2322, 05/2020, Volume 10, Issue 1, pp. 8274 - 8274
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Myometrium - ultrastructure | Green Fluorescent Proteins - metabolism | Antigens, CD34 - metabolism | Mice, Transgenic | Green Fluorescent Proteins - genetics | Myometrium - physiology | Uterine Contraction - physiology | Pregnancy | Tubulin - metabolism | Animals | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Myometrium - metabolism | Female | Models, Animal | Mice | Neuroimaging | CD34 antigen | Parturition | Myometrium | Tubulin | Uterus | Computational neuroscience | Green fluorescent protein | Transgenic mice | Muscles | Muscle contraction | Index Medicus
Journal Article
The Journal of immunology (1950), ISSN 0022-1767, 05/2018, Volume 200, Issue 9, pp. 3291 - 3303
Life Sciences & Biomedicine | Immunology | Science & Technology | Immunity, Mucosal - immunology | Adenocarcinoma - immunology | Humans | Middle Aged | Male | Immunologic Surveillance - immunology | T-Lymphocytes, Regulatory - immunology | Colorectal Neoplasms - immunology | Intestinal Mucosa - immunology | Female | Programmed Cell Death 1 Receptor | Aged | CD8-Positive T-Lymphocytes - immunology | Tumor Escape - immunology | Adenocarcinoma | CC chemokine receptors | Deregulation | Mucosal immunity | Anergy | PD-1 protein | Epithelial cells | CD8 antigen | Carbon tetrachloride | Colorectal carcinoma | Colorectal cancer | Cytotoxicity | Lymphocytes T | Drug development | Carcinogenesis | Metastases | CCR1 protein | Carcinogens | Lymphocytes | Intestine | Foxp3 protein | Immunoregulation | Immunosurveillance | Gene expression | Epithelium | Patients | Immunological tolerance | CD4 antigen | Surveillance | Stromal cells | Infiltration | CCR8 protein | Cancer | Tumors | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Esophagus : official journal of the Japan Esophageal Society, ISSN 1612-9059, 07/2020, Volume 18, Issue 1, pp. 33 - 40
Journal Article
Nature photonics, ISSN 1749-4885, 08/2012, Volume 6, Issue 8, pp. 540 - 544
Journal Article
Japanese journal of ophthalmology, ISSN 0021-5155, 01/2019, Volume 63, Issue 1, pp. 40 - 45
Journal Article
Cancer science, ISSN 1347-9032, 12/2019, Volume 110, Issue 12, pp. 3738 - 3745
non‐small‐cell lung cancer | interstitial lung disease | nab‐paclitaxel | carboplatin | exacerbation | Lung Neoplasms - drug therapy | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Carboplatin - administration & dosage | Paclitaxel - adverse effects | Albumins - administration & dosage | Male | Lung Diseases, Interstitial - complications | Carcinoma, Non-Small-Cell Lung - mortality | Carboplatin - adverse effects | Albumins - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Paclitaxel - administration & dosage | Lung Diseases, Interstitial - epidemiology | Thrombocytopenia | Pneumonia | Leukopenia | Toxicity | Lung cancer | Lung diseases | Non-small cell lung carcinoma | Cytotoxicity | Infections | Histology | Patients | Chemotherapy | Hospitals | Epidermal growth factor | Pulmonary fibrosis | Registration | Medical prognosis | Response rates | Paclitaxel | Carboplatin | Neutropenia | Pharmaceuticals | Index Medicus | Original
Journal Article